Modafinil treatment prevents METH-induced decrease in DAT immunoreactivity in the striatum. by Mariana Raineri (304307)

“…Average integrated density (% control) was determined in a region of interest in the dorsolateral striatum in mice (n = 5−8 sacrificed 48 hours (I) or 6 days (J) after the last METH injection. …”

GSPs decrease cell viability and induce cell death of HNSCC cells. by Ram Prasad (305524)

Factors associated with pneumococcal carriage in children <5 years in Uganda in 2009 (n = 587, missing = 20) and 2011 (n = 1024, missing = 18)^*. by Ann Lindstrand (3340458)

SF pretreatment inhibited the I/R induced decrease in the IRL thickness. by Hong Pan (8686)

Iminosugar-based GCS inhibitors decrease brain α-synuclein aggregates. by Karen M. Ashe (349018)

Iminosugar-based GCS inhibitors decrease brain GFAP positive cells. by Karen M. Ashe (349018)

Frequency of B cells increase and T cells decrease in MLN at 4 dpi. by Venkatramana D. Krishna (6716300)

KSHV and miR-K2 decrease anoikis of endothelial cells. by Philippe Kieffer-Kwon (454614)

Prioritising public information leads to an overall decrease in cooperation occurring in networks. by Adam Lee Miles (14123916)

Flow cytometry analysis of Annexin V/FITC-PI on SW480 and HCT116 cells treated with negative control, THC, βCD-THC inclusion complex, and camptothecin. by Zhi Xuan Low (19270163)

Inhibition of ATM kinase activity decreases H3K36me3 on the HPV31 genome and alters processing of late viral RNAs. by Dipendra Gautam (3215988)

Freezing test of acclimated and non-acclimated Col-0, <i>gun5</i> and <i>cch</i> plants. by Peter Kindgren (795049)

Disruption of poly-ADP-ribosylation decreases nucleolar CTCF, disrupts nucleolar structure, and increases <i>rDNA</i> expression. by Paola A. Guerrero (357587)

Identification of a Hydroxypyrimidinone Compound (<b>21</b>) as a Potent APJ Receptor Agonist for the Potential Treatment of Heart Failure by Wei Meng (505670)

“…Due to the increased polarity at C2, the permeability for these compounds decreased. Further adjustment of the polarity by replacing the N1 2,6-dimethoxyphenyl group with a 2,6-diethylphenyl group and reoptimization for the potency of the C5 pyrroloamides resulted in potent compounds with improved permeability. …”

Identification of a Hydroxypyrimidinone Compound (<b>21</b>) as a Potent APJ Receptor Agonist for the Potential Treatment of Heart Failure by Wei Meng (505670)

“…Due to the increased polarity at C2, the permeability for these compounds decreased. Further adjustment of the polarity by replacing the N1 2,6-dimethoxyphenyl group with a 2,6-diethylphenyl group and reoptimization for the potency of the C5 pyrroloamides resulted in potent compounds with improved permeability. …”

Identification of a Hydroxypyrimidinone Compound (<b>21</b>) as a Potent APJ Receptor Agonist for the Potential Treatment of Heart Failure by Wei Meng (505670)

“…Due to the increased polarity at C2, the permeability for these compounds decreased. Further adjustment of the polarity by replacing the N1 2,6-dimethoxyphenyl group with a 2,6-diethylphenyl group and reoptimization for the potency of the C5 pyrroloamides resulted in potent compounds with improved permeability. …”

PRMT5 stabilizes vCyclin protein expression in a manner dependent on its methyltransferase activity. by Danping Niu (10912688)

“…<p>(A-B) Effect of PRMT5 on vCyclin expression. First, HEK293T cells were cotransfected with fixed amounts of vCyclin expression plasmid and increasing amounts of PRMT5 expression plasmids. …”

The decrease in hBMVEC death is associated with reduced activation of Caspase-3. by Simona F. Spampinato (773594)

N100 amplitude decrease during 1 Hz-rTMS. by Christian Helfrich (297785)

“…Electrodes C3, CP3’ and CP5’ were pooled. <i>Left</i>: TMS-evoked N100 amplitude continuously decreased during the stimuli 1–500. …”

Hsp90 interacts with BMS1 and decreased Hsp90 function compromises 80S ribosome and polysome stability at 16°C. by Eric A. Franzosa (130063)